Citrullination of myofilament proteins in heart failure

Cardiovascular Research

Volumn 108, Issue 2, 2015, Pages 232-242

  Fert Bober, Justyna ^a,b   Giles, John T ^c   Holewinski, Ronald J ^a   Kirk, Jonathan A ^b   Uhrigshardt, Helge ^b   Crowgey, Erin L ^a   Andrade, Felipe ^b   Bingham, Clifton O ^b,d   Park, Jin Kyun ^b,d   Halushka, Marc K ^b   Kass, David A ^b   Bathon, Joan M ^c   Van Eyk, Jennifer E ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Columbia University ^*  (United States)

^d Seoul National University Hospital   (South Korea)

Author keywords

Citrullination; Heart failure; Myofilament; Peptidylarginine deiminases; Sarcomere

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM; F ACTIN; MYOFILAMENT PROTEIN; MYOSIN; PROTEIN; PROTEIN ARGININE DEIMINASE; UNCLASSIFIED DRUG; CITRULLINE; CYTOSKELETON PROTEIN; HYDROLASE; MYOSIN SUBFRAGMENT; PROTEIN-ARGININE DEIMINASE; PROTEOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; MASS SPECTROMETRY; METABOLISM; MUSCLE FIBRIL; NEWBORN; PROCEDURES;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANIMALS, NEWBORN; CITRULLINE; CYTOSKELETAL PROTEINS; HEART FAILURE; HUMANS; HYDROLASES; MALE; MASS SPECTROMETRY; MICE, INBRED C57BL; MYOCARDIUM; MYOFIBRILS; MYOSIN SUBFRAGMENTS; PROTEOME;

EID: 84945303618     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv185     Document Type: Article

References (45)

1. Jang B, Kim E, Choi JK, Jin JK, Kim JI, Ishigami A, Maruyama N, Carp RI, Kim YS, Choi EK. Accumulation of citrullinated proteins by up-regulated peptidylargininedeiminase 2 in brains of scrapie-infected mice: a possible role inpathogenesis. Am J Pathol 2008;173:1129-1142.
2. Chang X, Han J. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol Carcinog 2006;45:183-196.
3. Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z. Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 2009;9:40.
4. Mastronardi FG, Noor A, Wood DD, Paton T, Moscarello MA. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J Neurosci Res 2007;85:2006-2016.
5. Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, Murayama S, Asaga H, Toda T, Kimura N, Maruyama N. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 2005;80:120-128.
6. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-163.
7. Giles JT, Fert-Bober J, Park JK, Bingham CO III, Andrade F, Fox-Talbot K, Pappas D, Rosen A, van Eyk J, Bathon JM, Halushka MK. Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res Ther 2012;14:R39.
8. LeWinter MM. Functional consequences of sarcomeric protein abnormalities in failing myocardium. Heart Fail Rev 2005;10:249-257.
9. Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Ten Cate H, Hofstra L, Crijns HJ, Wagner DD, Kietselaer BL. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 2013;33:2032-2040.
10. Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 1996;271:30709-30716.
11. Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 2000;39:5374-5381.
12. Fan LY, He DY, Wang Q, Zong M, Zhang H, Yang L, Sun LS. Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis. Scand J Rheumatol 2012;41:354-358.
13. Gyorgy B, Toth E, Tarcsa E, Falus A, Buzas EI. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol 2006;38:1662-1677.
14. Jones JE, Causey CP, Knuckley B, Slack-Noyes JL, Thompson PR. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr Opin Drug Discov Devel 2009;12:616-627.
15. Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205.
16. Snaidecki B, Solaro J. When hearts fail so does skeletal muscle. Breaking a vicious cycle. Circ Res 2006;98:1456-1458.
17. Luo M, Anderson ME. Ca2+ cycling in heart failure. Circ Res 2013;6:690-708.
18. Solaro RJ, Sheehan KA, Lei M, Ke Y. The curious role of sarcomeric proteins in control of diverse processes in cardiac myocytes. J Gen Physiol 2010;136:13-19.
19. Shannon TR, Pogwizd SM, Bers DM. Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ Res 2003;93:592-594.
20. De Ceuleneer M, Van Steendam K, Dhaenens M, Deforce D. In vivo relevance of citrullinated proteins and the challenges in their detection. Proteomics 2012;12:752-760.
21. Zhang P, Kirk JA, Ji W, dos Remedios CG, Kass DA, Van Eyk JE, Murphy AM. Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation 2012;126:1828-1837.
22. Koitabashi N, Aiba T, Hesketh GG, Rowell J, Zhang M, Takimoto E, Tomaselli GF, Kass DA. Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation: novel mechanism of cardiac stress modulation by PDE5 inhibition. J Mol Cell Cardiol 2010;48:713-724.
23. Kane LA, Neverova I, Van Eyk JE. Subfractionation of heart tissue: the 'in sequence' myofilament protein extraction of myocardial tissue. Methods Mol Biol 2007;357: 87-90.
24. Romero V, Fert-Bober J, Nigrovic PA, Darrah E, Haque UJ, Lee DM, van Eyk J, Rosen A, Andrade F. Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci Transl Med 2013;5:209ra150.
25. Escher C, Reiter L, MacLean B, Ossola R, Herzog F, Chilton J, MacCoss MJ, Rinner O. Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 2012;12:1111-1121.
26. Natale DA, Arighi CN, Blake JA, Bult CJ, Christie KR, Cowart J, D'Eustachio P, Diehl AD, Drabkin HJ, Helfer O, Huang H, Masci AM, Ren J, Roberts NV, Ross K, Ruttenberg A, Shamovsky V, Smith B, Yerramalla MS, Zhang J, AlJanahi A, Çelen I, Gan C, Lv M, Schuster-Lezell E, Wu CH. Protein Ontology: a controlled structured network of protein entities. Nucleic Acids Res 2014;42:D415-D421.
27. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang PL, Lotia S, Pico AR, Bader GD, Ideker T. A travel guide to Cytoscape plugins. Nat Methods 2012;9:1069-1076.
28. Matt P, Fu Z, Fu Q, Van Eyk JE. Biomarker discovery: proteome fractionation and separation in biological samples. Physiol Genomics 2008;33:12-17.
29. Kirk JA, Holewinski RJ, Kooij V, Agnetti G, Tunin RS, Witayavanitkul N, de Tombe PP, Gao WD, Van Eyk J, Kass DA. Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3beta. J Clin Invest 2014;1:129-138.
30. White HD. Special instrumentation and techniques for kinetic studies of contractile systems. Methods Enzymol 1982;85:698-708.
31. Tauhata SB, dos Santos DV, Taylor EW, Mooseker MS, Larson RE. High affinity binding of brain myosin-Va to F-actin induced by calcium in the presence of ATP. J Biol Chem 2001;276:39812-39818.
32. Skorzewski R, Sliwinska M, Borys D, Sobieszek A, Moczarewska J. Effect of actin C-terminal modification on tropomyosin isoforms binding and thin filament regulation. Biochim Biophys Acta 2009;2:237-243.
33. Nascimento AA, Cheney RE, Tauhata SB, Larson RE, Mooseker MS. Enzymatic characterization and functional domain mapping of brain myosin-V. J Biol Chem 1996;271:17561-17569.
34. Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, Bonner R, Aebersold R. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 2012;11:O111 016717.
35. Galinska A, Hatch V, Craig R, Murphy AM, Van Eyk JE, Wang CL, Lehman W, Foster DB. The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments. Circ Res 2010;106:705-711.
36. Eaton BL. Tropomyosin binding to F-actin induced by myosin heads. Science 1976;192: 1337-1339.
37. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009;37:D412-D416.
38. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-2504.
39. Lehman W, Craig R. Tropomyosin and the steric mechanism of muscle regulation. Adv Exp Med Biol 2008;644:95-109.
40. Mijailovich SM, Kayser-Herold O, Li X, Griffiths H, Geeves MA. Cooperative regulation of myosin-S1 binding to actin filaments by a continuous flexible Tm-Tn chain. Eur Biophys J 2012;12:1015-1032.
41. Palmer S, Kentish JC. The role of troponin C in modulating the Ca2″ sensitivity of mammalian skinned cardiac and skeletal muscle fibres. J Physiol 1994;480:45-60.
42. Lehman W, Galinska-Rakoczy A, Hatch V, Tobacman LS, Craig R. Structural basis for the activation of muscle contraction by troponin and tropomyosin. J Mol Biol 2009;388:673-681.
43. Wang H, Chalovich JM, Marriott G. Structural dynamics of troponin I during Ca2+activation of cardiac thin filaments: a multi-site Forster resonance energy transfer study. PLoS ONE 2012;7:e50420.
44. Szczesna D, Ghosh D, Li Q, Gomes AV, Guzman G, Arana C, Zhi G, Stull JT, Potter JD. Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation. J Biol Chem 2001;276:7086-7092.
45. Marston SB. How do mutations in contractile proteins cause the primary familial cardiomyopathies? J Cardiovasc Transl Res 2011;4:245-255.